Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: results of a phase II trial-Reference-Cited by-同舟云学术

Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: results of a phase II trial

Published:2007-09-25 Issue:2 Volume:139 Page:224-233
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Cohen Adam D.,Zhou Ping,Chou Joanne,Teruya-Feldstein Julie,Reich Lilian,Hassoun Hani,Levine Beth,Filippa Daniel A.,Riedel Elyn,Kewalramani Tarun,Stubblefield Michael D.,Fleisher Martin,Nimer Stephen,Comenzo Raymond L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2007.06783.x/fullpdf

Reference42 articles.

1. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma;Attal;Blood,2006

2. Autologous stem cell transplantation for primary systemic amyloidosis;Comenzo;Blood,2002

3. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis;Comenzo;British Journal of Haematology,1999a

4. Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation;Comenzo;British Journal of Haematology,1999b

5. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden;Comenzo;Blood,2001

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

2. Role of Autologous Stem Cell Transplantation in Systemic Light Chain Amyloidosis;Clinical Lymphoma Myeloma and Leukemia;2024-07

3. Treatment of AL amyloidosis in the era of novel immune and cellular therapies;Frontiers in Oncology;2024-06-28

4. Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management;Journal of Clinical Medicine;2024-03-18

5. Cardiovascular toxicity from therapies for light chain amyloidosis;Frontiers in Cardiovascular Medicine;2023-07-05